RAS mutations distribution in a 108 patients series of colorectal cancer

Autor: Azueta, Ainara, González-Sánchez, Ruth, Caballero, Clara I., Freire, Javier, García-Berbel, Pilar, Pereda, Saray, Rivera, Fernando, Gómez-Román, Javier
Zdroj: Pathology; January 2014, Vol. 46 Issue: 1, Number 1 Supplement 2 pS117-S117, 1p
Abstrakt: As described previously in high impact studies,1patients with other activating RAS out of codon 2 of kras mutations may also be negative predictive biomarkers for anti-EGFR therapy. Here we present the description of a new series in which has been performed the analysis of mutations in KRAS and NRAS genes.
Databáze: Supplemental Index